ALK’s Licensing Agreement with ARS Pharmaceuticals

Leila Ahmed Europe Legal Chronicle
Tagged:

Covington & Burling advised ALK-Abelló A/S on the deal.ALK-Abelló A/S (ALK) and ARS Pharmaceuticals, Inc. (ARS Pharma) (Nasdaq: SPRY) announced a strategic license agreement. The agreement…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here